Form 4 for ELV Elevance Health
Accepted 2021-10-29 00:00:00 ET · period of report 2021-10-28 · accession 0001156039-21-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-29 | 2021-10-28 | ELV | Penczek Ronald W | SVP, CAO | S - Sale | $436.00 | -1,150 | 2,009 | -36% | -$501.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-28 | S | D | 1,150 | $436.00 | 2,009 | D | — | — | (F1) Balance includes 7.79 shares acquired on March 25, 2021, 7.34 shares acquired on June 25, 2021 and 7.37 shares acquired on September 24, 2021 through a dividend reinvestment plan. |